Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 21;219(1):uxad122.
doi: 10.1093/cei/uxad122.

Gender-affirming hormone therapy and autoimmunity: new insights from a 3-year follow-up study

Matteo Marconi  1 , Gloria Riitano  2 , Alessandra Daphne Fisher  3 , Carlotta Cocchetti  3 , Maria Teresa Pagano  4 , Antonella Capozzi  2 , Agostina Longo  2 , Sara D'Arienzo  5 , Linda Vignozzi  3 , Maurizio Sorice  2 , Elena Ortona  1 , Marina Pierdominici  1
Affiliations

Gender-affirming hormone therapy and autoimmunity: new insights from a 3-year follow-up study

Matteo Marconi et al. Clin Exp Immunol. .
No abstract available

Keywords: autoantibodies; autoimmune diseases; gender affirming hormone therapy; gender medicine; transgender.

PubMed Disclaimer

Conflict of interest statement

The authors declare no financial or commercial conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, et al. . Standards of care for the health of transgender and gender diverse people, Version 8. Int J Transgend Health 2022, 23, S1–S259. doi:10.1080/26895269.2022.2100644 - DOI - PMC - PubMed
    1. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. . Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline [published correction appears in J Clin Endocrinol Metab 2018 Feb 1;103(2):699] [published correction appears in J Clin Endocrinol Metab 2018 Jul 1;103(7):2758-2759]. J Clin Endocrinol Metab 2017, 102, 3869–903. doi:10.1210/jc.2017-01658 - DOI - PubMed
    1. Goldstein Z, Khan M, Reisman T, Safer JD.. Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy. J Blood Med 2019, 10, 209–16. doi:10.2147/JBM.S166780 - DOI - PMC - PubMed
    1. Wilkinson NM, Chen HC, Lechner MG, Su MA.. Sex differences in immunity. Annu Rev Immunol 2022, 40, 75–94. doi:10.1146/annurev-immunol-101320-125133 - DOI - PMC - PubMed
    1. Klein SL, Flanagan KL.. Sex differences in immune responses. Nat Rev Immunol 2016, 16, 626–38. doi:10.1038/nri.2016.90 - DOI - PubMed